1. Home
  2. IMNM vs ODC Comparison

IMNM vs ODC Comparison

Compare IMNM & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • ODC
  • Stock Information
  • Founded
  • IMNM 2006
  • ODC 1941
  • Country
  • IMNM United States
  • ODC United States
  • Employees
  • IMNM N/A
  • ODC N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • ODC Miscellaneous manufacturing industries
  • Sector
  • IMNM Health Care
  • ODC Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • ODC Nasdaq
  • Market Cap
  • IMNM 748.3M
  • ODC 853.6M
  • IPO Year
  • IMNM 2020
  • ODC N/A
  • Fundamental
  • Price
  • IMNM $8.84
  • ODC $60.33
  • Analyst Decision
  • IMNM Strong Buy
  • ODC
  • Analyst Count
  • IMNM 5
  • ODC 0
  • Target Price
  • IMNM $26.40
  • ODC N/A
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • ODC 81.7K
  • Earning Date
  • IMNM 08-11-2025
  • ODC 06-05-2025
  • Dividend Yield
  • IMNM N/A
  • ODC 1.19%
  • EPS Growth
  • IMNM N/A
  • ODC 17.38
  • EPS
  • IMNM N/A
  • ODC 3.40
  • Revenue
  • IMNM $10,938,000.00
  • ODC $474,062,000.00
  • Revenue This Year
  • IMNM N/A
  • ODC N/A
  • Revenue Next Year
  • IMNM $310.65
  • ODC N/A
  • P/E Ratio
  • IMNM N/A
  • ODC $17.76
  • Revenue Growth
  • IMNM N/A
  • ODC 9.92
  • 52 Week Low
  • IMNM $5.15
  • ODC $29.47
  • 52 Week High
  • IMNM $16.81
  • ODC $60.70
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 50.27
  • ODC 68.88
  • Support Level
  • IMNM $8.35
  • ODC $56.28
  • Resistance Level
  • IMNM $9.34
  • ODC $60.70
  • Average True Range (ATR)
  • IMNM 0.53
  • ODC 1.90
  • MACD
  • IMNM -0.07
  • ODC -0.08
  • Stochastic Oscillator
  • IMNM 33.97
  • ODC 93.07

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: